Methodology v3.0

The SAFE Scoring Methodology

A rigorous, transparent framework for evaluating femtech products across four weighted dimensions.

Created by Bethany Corbin, femtech advocate and author.

Each femtech product reviewed receives a SAFE Score from 0 to 100, based on four dimensions: Security & Privacy, Accuracy, Foundation, and Equity. We review publicly available information including research publications, regulatory filings, company websites, app store descriptions, marketing materials, and privacy policies.

Product Classification

Before scoring, every product is classified as either Medical or Wellness. In v3.0, this classification no longer affects the scoring weights — the same formula applies to both. However, classification still matters for how sub-criteria are interpreted, particularly in the Accuracy dimension.

Medical

A product is Medical if any of the following are true:

  • Has FDA clearance, approval, or equivalent
  • Makes diagnostic, prognostic, or treatment claims
  • Marketed as a medical device or digital therapeutic
  • Requires a prescription or clinical referral
Wellness

A product is Wellness if:

  • Does not make clinical or diagnostic claims
  • Positioned as general health, tracking, or education
  • Available directly to consumers without clinical gatekeeping
  • E.g. period trackers, health education platforms, wellness wearables

Edge cases: When a product has both wellness and medical features, classify based on the primary marketed use case. When in doubt, classify as Medical — the higher standard protects users.

Unified Scoring Formula

As of v3.0, all products — Medical and Wellness — are scored using the same dimension weights. The weights reflect the dimensions that matter most to consumers regardless of product type. Each dimension is scored on a raw scale of 0 to 25 using the sub-criteria below, then converted to weighted scores.

Dimension Weight Rationale
S — Security & Privacy 35% Always high — core to brand promise and consumer trust
A — Accuracy 35% Critical for clinical claims; still essential for wellness products making health representations
F — Foundation 15% Matters for trust but not the primary consumer deciding factor
E — Equity 15% Important across all product types; scored with context for each

Formula

SAFE Score = (S × 1.40) + (A × 1.40) + (F × 0.60) + (E × 0.60)

Maximum score check: (25 × 1.40) + (25 × 1.40) + (25 × 0.60) + (25 × 0.60) = 35 + 35 + 15 + 15 = 100

A multiplier of 1.00 means the dimension contributes exactly 25% of the total. A multiplier of 1.40 means the dimension is weighted 35% (25 × 1.40 = 35 max points).

Dimension Sub-Criteria & Point Values

Each dimension is scored out of 25 raw points distributed across specific, observable sub-criteria. For each sub-criterion: full points = clear, strong evidence; partial points = some evidence with gaps; zero points = no evidence or significant problems.

S — Security & Privacy (0–25 raw points)

How well does the product protect user data?

5 pts
Data minimization — Does the product collect only what's necessary for core functionality?
5 pts
Privacy policy clarity — Is the policy specific, readable, and non-vague? Does it clearly state what's collected and why?
5 pts
User control and consent — Can users opt out of non-essential collection? Is there a clear deletion/account closure process?
4 pts
Third-party sharing practices — Is sharing limited and specific, or broad/open-ended?
3 pts
Security infrastructure — Encryption (transit + rest), MFA, compliance standards (SOC 2, HIPAA, ISO 27001), audit practices.
3 pts
Track record — Any known breaches, regulatory actions, or public controversies? Can score −2 for major unresolved incidents.

A — Accuracy (0–25 raw points)

Are health claims supported by evidence and appropriate regulatory status?

4 pts
Regulatory status — FDA cleared/approved or equivalent? Does regulatory status match claims being made? (N/A for wellness products with no clinical claims.)
8 pts
Clinical validation and evidence — Peer-reviewed studies? Study design quality, sample size, population relevance. White papers or pilot data?
6 pts
Medical/institutional partnerships — Substantive relationships with hospitals, academic institutions, or recognized health organizations?
4 pts
Independent reviews and user-reported effectiveness — Independent evaluations? Consistent user reports? Common complaints about accuracy?
3 pts
Transparency about limitations — Does the product clearly disclose what it can and cannot do? Are disclaimers present and honest?

F — Foundation (0–25 raw points)

Is the company credible, transparent, and mission-aligned?

6 pts
Leadership experience and credibility — Founders/leaders with relevant experience in women's health, healthcare, or related fields? Diverse leadership?
5 pts
Mission and vision clarity — Specific, actionable commitment to women's health? Or generic/missing mission statement?
5 pts
Advisory board and clinical consultants — Advisors with backgrounds in women's health, research, bioethics, regulatory?
4 pts
Thought leadership and public engagement — Leaders speak publicly on women's health, equity, or related topics? Any public red flags?
5 pts
Marketing alignment with values — Marketing reflects respect, inclusivity, evidence-based care? Or overpromising, fear-based, exploitative?

E — Equity (0–25 raw points)

Does the product intentionally serve diverse users and advance health equity?

5 pts
Accessibility and inclusive design — Multilingual support, plain language, screen-reader compatibility, adjustable UI, culturally relevant content?
5 pts
Diverse representation — Imagery, testimonials, and branding reflect diversity (race, body size, age, disability, gender identity)?
6 pts
Economic accessibility — Insurance accepted (incl. Medicaid)? Sliding scale, student/low-income discounts? Free tier that's actually usable?
5 pts
Community and advocacy engagement — Supports health equity initiatives? Partners with community health programs?
4 pts
Designed for actual diverse users — Evidence the product works for diverse bodies/situations (not just assumed default)?

Handling Missing Information

Absence of information is not the same as negative information. Missing information means we could not find evidence one way or the other. Negative information means we found evidence of a problem.

Scenario How to Score Example
Information exists and is positive Full or partial points based on quality Clear, specific privacy policy with user controls
Information exists and is negative Zero points or negative Privacy policy reveals data sold to brokers
Information is missing (should exist) Half the available points, rounded down No public privacy policy for a health app = 2/5
Information is missing (not expected) Mark as N/A; redistribute points Wellness education site with no reason for FDA status

Every scorecard includes a "What We Couldn't Find" section listing any sub-criteria scored as missing or N/A, with an explanation of what information was sought and where we looked.

Minimum Dimension Thresholds

A high composite score can mask a critical weakness in a single dimension. To prevent this, minimum dimension thresholds apply before a product can receive a positive rating.

80 – 100
Excellent

Requires 15/25 in every dimension. If any dimension < 15, capped at Good.

SAFE Recommended — a product you can feel confident about.

60 – 79
Good

Requires 10/25 in every dimension. If any dimension < 10, capped at Poor.

Use with awareness — check the dimension breakdown.

0 – 59
Poor

No minimum threshold. Score stands as calculated.

Proceed with caution — review the specific concerns before using.

Example: A product scores S=22, A=24, F=20, E=7. The composite calculates to (22×1.40)+(24×1.40)+(20×0.60)+(7×0.60) = 30.8+33.6+12+4.2 = 80.6, which falls in the Excellent range. However, E=7 is below the minimum threshold of 15 for Excellent and also below 10 for Good. The product is therefore capped at Poor despite its high composite. When a cap is applied, the scorecard shows which dimension triggered it.

Meets SAFE Standard

The SAFE Standard Badge

Products that score 80 or above with no individual dimension below 15/25 earn the "Meets SAFE Standard" designation. This indicates the product has demonstrated strong performance across all four evaluation dimensions.

This is an informational designation based on our standardized evaluation criteria. It reflects the results of the SAFE scoring methodology and is not a product endorsement. Consumers should consider their individual needs when choosing health technology.

Our Review Process

Every evaluation is based on publicly available evidence. We review:

Score Disputes & Reconsideration

We believe in fairness and accuracy. If a product manufacturer or user believes a score does not accurately reflect a product's current state, we offer a formal reconsideration process.

1

Submit a Request

Email us at hello@safefemtech.com with the product name, the specific dimension(s) you believe should be reconsidered, and supporting evidence.

2

Evidence Review

Our team reviews the submitted evidence against the SAFE criteria. We may request additional documentation or clarification.

3

Decision & Update

If the evidence warrants a score adjustment, we update the scorecard and notify the requester. All decisions are documented for transparency.

Reconsideration requests are typically reviewed within 14 business days. Score adjustments are based solely on evidence — not on the identity of the requester.

100% Independent

The SAFE Standard for Femtech maintains complete independence from product manufacturers. We do not accept payment for reviews, and products cannot buy better scores. All evaluations are based solely on publicly available evidence and our standardized methodology.